Skip to content
WeighLab
Menu

Head-to-head · Cost-Efficiency Index

Nalena vs He & She MD

Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.

Better valueGrade C · #60

Nalena

Cost-first shoppers who want women-focused GLP-1-only platform with no membership or hidden fees.

Visit Nalena
VS
Grade C · #65

He & She MD

Shoppers comparing injectable semaglutide specifically, where the advertised $199 genuinely is the standing price — not oral semaglutide or tirzepatide, which roll higher after 6 months.

Visit He & She MD

The verdict

Winner · NalenaGrade C vs C

Nalena takes it, leading the Cost-Efficiency Index 74 to 71. Nalena is a women-focused, GLP-1-only telehealth platform offering compounded semaglutide and tirzepatide with medication included — no separate membership or visit fees. He & She MD still earns a CShoppers comparing injectable semaglutide specifically, where the advertised $199 genuinely is the standing price — not oral semaglutide or tirzepatide, which roll higher after 6 months.

Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Nalena.

Factor by factor

Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.

Normalized Cost/Month

70
51

Price Transparency

78
78

Nationwide Access

86
86

Formulation Options

66
90

Clinical Oversight

82
85

Contract Flexibility

61
33

Pricing, coverage & formulary

The disclosed facts behind the scores. Lower price wins its row (teal).

SpecNalenaHe & She MD
Cost-Efficiency Index74/10071/100
Semaglutide / mo$149/mo (starting dose, compounded)$199/mo (month to month, compounded; every lower rate is a prepaid term)
Tirzepatide / mo$149/mo (starting dose, compounded)$299/mo (month to month, compounded; every lower rate is a prepaid term)
Semaglutide / yr (modeled)$1,788$2,388
Tirzepatide / yr (modeled)$1,788$2,388
CoverageAll 50 statesAll states except Louisiana (GLP-1)
Oral / sublingualNoYes
Brand-name accessCompounded onlyYes
Rank here#60#65

Nalena

74/100

Where the value is

  • Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
  • Transparent fee model: no hidden fees, no membership, cancel anytime
  • Money-back guarantee — uncommon among compounded telehealths

The tradeoffs

  • Per-dose pricing not published — only the 'starting at $149' entry price
  • No LegitScript, HIPAA, or NABP badges on public pages
Visit Nalena

Full Nalena review →

He & She MD

71/100

Where the value is

  • Compounded semaglutide and tirzepatide (injectable or oral), with brand-name access to Ozempic, Wegovy, and Zepbound also offered
  • Named pharmacy (F&F Pharmacies Inc DBA Jungle Jim's Pharmacy, Fairfield OH) and named CMO (Dr. Ozita Cooper, MD)
  • Free expedited shipping and unlimited board-certified clinician access

The tradeoffs

  • Its own FAQ says the pharmacy it names holds a license in 44 US states, none in California, Nevada, New Jersey, North Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia or Delaware, and “cannot dispense sterile compounds” — while the same FAQ says GLP-1s ship everywhere except Louisiana. Injectable GLP-1s are sterile compounds, and the site never says which of its two pharmacies covers the gap
  • The uniform '$199 to start' banner across all three tracks obscures that only injectable semaglutide holds at $199 ongoing — oral semaglutide rolls to $239/mo and injectable tirzepatide rolls to $289/mo after the first 6-month cycle
Visit He & She MD

Full He & She MD review →

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.

Keep comparing

← All head-to-head comparisons